Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00750594 · ClinicalTrials.gov registry record
Patent Foramen Ovale in Children With Migraine Headaches
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 109
- Enrollment target
NCT00750594: Completed study, sponsored by University of Utah.
NCT00750594 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00750594 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 109 participants
- Enrollment target
Study Summary
This study will be the first to provide data about the relationship between PFO and migraine in children. By establishing the actual prevalence, we will better understand if PFO plays a role in the occurence of pediatric migraine and, thus, provide the incentive to perform additional studies evaluating whether PFO closure is an effective treatment option for pediatric migraine. For children with migraine headaches, discovering novel and effective treatments would be life altering.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-03 |
What the finished NCT00750594 record still lists
NCT00750594 is an observational study that tracks outcomes without assigning an intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00750594 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00750594 about?
NCT00750594 is a clinical study titled "Patent Foramen Ovale in Children With Migraine Headaches". This study will be the first to provide data about the relationship between PFO and migraine in children. By establishing the actual prevalence, we will better understand if PFO plays a role in the occurence of pediatric migraine and, thus, provide the incentive to perform additional studies evaluat...
What is the current status of trial NCT00750594?
This trial is currently completed. The enrollment target is 109 participants. The study started on 2008-04. Estimated completion is 2011-03.
Who is sponsoring clinical trial NCT00750594?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02421380 · 109 participants · NA
Characterization of Hyperpolarized Pyruvate MRI Reproducibility
- NCT04526600 · 109 participants · NA
Fidgeting and Attentional and Emotional Regulation in ADHD
- NCT04835584 · 109 participants · Phase 1
KRT-232 and TKI Study in Chronic Myeloid Leukemia
- NCT06626516 · 109 participants · Phase 1
Tebentafusp-tebn With LDT in Metastatic UM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia